Tang Capital Management »

Dianthus Therapeutics shares owned by Tang Capital Management

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Tang Capital Management from 13F filings

Historical chart of Tang Capital Management investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Tang Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Tang Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.2M 504k 10.40
2023-09-30 $8.1M 592k 13.67

More positions owned by Tang Capital Management

Mirati Therapeutics
ImmunoGen
Tarsus Pharmaceuticals (TARS)
Kalvista Pharmaceuticals (KALV)
Lianbio Sponsored Ads (LIANY)
Anaptysbio Inc Common (ANAB)
Mirum Pharmaceuticals (MIRM)
Evolus (EOLS)
Altimmune Com New (ALT)
Immunocore Hldgs Ads (IMCR)
Axsome Therapeutics (AXSM)
Ptc Therapeutics I (PTCT)
Gracell Biotechnologies Sponsored Ads
Revolution Medicines (RVMD)
Vaxcyte (PCVX)

View all positions for Tang Capital Management

Top funds holding Dianthus Therapeutics

Fairmount Funds Management
5AM Venture Management
Avidity Partners Management
VR Adviser
Octagon Capital Advisors
Tang Capital Management
Nantahala Capital Management
Atlas Venture Life Science Advisors
Alphabet
Vanguard Group
Fred Alger Management
Millennium Management
Laurion Capital Management
Hussman Econometrics Advisors
Arrowpoint Asset Management

View all funds holding Dianthus Therapeutics